{"entity":{"id":"eureka-therapeutics","kind":"company","name":"Eureka Therapeutics","aka":["Eureka Therapeutics Inc."],"tldr":"Eureka Therapeutics is a US-based cell therapy company that leads 2 cancer trials in OnCo, testing the ARTEMIS T-cell therapies ECT204 and ET140203 in hepatoblastoma and hepatocellular carcinoma.","summary":"Eureka Therapeutics is a clinical-stage biopharmaceutical company developing T-cell therapies for solid tumours using its E-ALPHA antibody discovery and ARTEMIS T-cell receptor platforms. Its clinical programmes are ECT204 for GPC3-positive adult liver cancer and ET140203 for AFP-positive paediatric liver cancer. On ClinicalTrials.gov it is the lead sponsor of 2 trials recorded in OnCo: NCT04634357 (phase 1/2, ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular...) and NCT04864054 (phase 1/2, GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC). Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.","asOf":"2026-09-17","links":[{"label":"Official website","url":"https://www.eurekatherapeutics.com"},{"label":"ClinicalTrials.gov: trials led by Eureka Therapeutics","url":"https://clinicaltrials.gov/search?lead=Eureka%20Therapeutics%20Inc."}],"tags":["ctgov-sponsor"],"related":[],"cancers":["hepatoblastoma","hcc"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["nct04634357","nct04864054"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"provenance":{"editedBy":"OnCo orphan-trial linking round (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-17"},"hq":"Emeryville, California","country":"US","companyType":"cell-therapy","website":"https://www.eurekatherapeutics.com","founded":2006,"stage":"growth","investors":[],"funding":[]},"route":"/companies/eureka-therapeutics/","neighbours":{"cancer":[{"id":"hepatoblastoma","kind":"cancer","name":"Hepatoblastoma","route":"/cancers/hepatoblastoma/"},{"id":"hcc","kind":"cancer","name":"Hepatocellular carcinoma","route":"/cancers/hcc/"}],"trial":[{"id":"nct04634357","kind":"trial","name":"ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma","route":"/trials/nct04634357/"},{"id":"nct04864054","kind":"trial","name":"GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC","route":"/trials/nct04864054/"}]}}